Tim-3 finds its place in the cancer immunotherapy landscape

Nandini Acharya, Catherine Sabatos-Peyton, Ana Carrizosa Anderson

Open source

DOI: 10.1136/jitc-2020-000911
Published: 2020-06
Container: Journal for ImmunoTherapy of Cancer
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2020-000911,
  title = {Tim-3 finds its place in the cancer immunotherapy landscape},
  author = {Nandini Acharya and Catherine Sabatos-Peyton and Ana Carrizosa Anderson},
  year = {2020},
  journal = {Journal for ImmunoTherapy of Cancer},
  doi = {10.1136/jitc-2020-000911},
  url = {https://doi.org/10.1136/jitc-2020-000911}
}

RIS

TY  - JOUR
TI  - Tim-3 finds its place in the cancer immunotherapy landscape
AU  - Nandini Acharya
AU  - Catherine Sabatos-Peyton
AU  - Ana Carrizosa Anderson
PY  - 2020
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2020-000911
UR  - https://doi.org/10.1136/jitc-2020-000911
ER  -

APA

Acharya, N., Sabatos-Peyton, C., & Anderson, A. C. (2020). Tim-3 finds its place in the cancer immunotherapy landscape. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2020-000911

Source records

crossref · retrieved 2026-09-25T10:54:09.774Z